Pfizer delays drug launch pending DEA classification

06/14/2005 | TheStreet.com

Pfizer says it is almost ready to launch Lyrica for treating epilepsy, nearly a year after the FDA approved the medicine. The company is awaiting a decision from the Drug Enforcement Administration, which will dictate the level of controlled substance Lyrica, intended for relieving nerve pain from diabetes and shingles, will be classified as.

View Full Article in:

TheStreet.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Chief Financial Officer
B. E. Smith
Miramar, FL